Visterra Signs Antibody Discovery Collaboration Deal With Pfizer

Visterra Signs Antibody Discovery Collaboration Deal With Pfizer

September 11, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra Inc., developer of novel therapeutics to treat major diseases, announced today that it has entered into a collaboration agreement with Pfizer to discover novel antibodies using Visterra’s proprietary platform.   

Visterra Presents Preclinical Results that Shows 100% Prevention and Treatment of Influenza with VIS410, a Novel Engineered Human Antibody

Visterra Presents Preclinical Results that Shows 100% Prevention and Treatment of Influenza with VIS410, a Novel Engineered Human Antibody

September 10, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra, Inc., developer of novel therapeutics to treat major diseases, today announced the presentation of positive data from a preclinical study evaluating the efficacy of the company’s lead product candidate, VIS410, a broadly protective, fully human monoclonal antibody being developed for influenza A infections.

Joule Elects Caroline Dorsa to Board of Directors

Joule Elects Caroline Dorsa to Board of Directors

September 4, 2012

Bedford, MA – September 4, 2012 – Joule today announced the election of Caroline Dorsa to its board of directors, adding the expertise and insight of a highly experienced financial executive who will also serve as Chair of the company's audit committee.

Startup WikiCell Designs Secures $10 Million in Investment Capital from Flagship Ventures and Polaris Venture Partners

Startup WikiCell Designs Secures $10 Million in Investment Capital from Flagship Ventures and Polaris Venture Partners

September 4, 2012

Company Anticipates Introduction of First Edible Packaged Products in 2013

BG Medicine, Inc. Announces Publication of Important Galectin-3 Study Designed to Identify Adults in General Population at Risk for Heart Failure

BG Medicine, Inc. Announces Publication of Important Galectin-3 Study Designed to Identify Adults in General Population at Risk for Heart Failure

August 30, 2012

Study Reports in Journal of American College of Cardiology That Those in General Population With Elevated Galectin-3 Levels Have Significantly Increased Risk of Developing Heart Failure

LS9 HIRES JONATHAN FOSTER AS CHIEF FINANCIAL OFFICER

LS9 HIRES JONATHAN FOSTER AS CHIEF FINANCIAL OFFICER

August 28, 2012

South san francisco, CA (August 28, 2012) – LS9, Inc., a technology leader in the development of renewable and sustainable chemicals and fuels, today announced that Jon Foster has joined the Company as its Chief Financial Officer (CFO), effective today. In this role, Mr. Foster will be responsible for management of the firm's financial and related functions.

Water Trumping Carbon Spreads $17 Billion Market

Water Trumping Carbon Spreads $17 Billion Market

August 23, 2012

Desalination equipment orders are forecast to triple over five years to become a $17 billion business, driven by breakthroughs in energy savings and demand by cities and industry.

Swing Voters Prefer Women for VP Picks on Both 2012 Presidential Tickets

Swing Voters Prefer Women for VP Picks on Both 2012 Presidential Tickets

August 22, 2012

Results from a new survey based on evolutionary algorithms show Condoleezza Rice and Hillary Clinton would have made strong running mates for Romney and Obama 

Top cities for technology start-ups

Top cities for technology start-ups

August 23, 2012

LOS ANGELES – It's a given that the San Francisco area, including Silicon Valley, is the technology capital of the world. Seven of the top 10 most-visited websites are based there, including Google, Yahoo, Facebook and Ask.

Seahorse Bioscience Ranks No. 1600 on the Inc. 500|5000 List of Fastest-Growing Private Companies in America for 2012 with Three-Year Sales Growth of 183%

Seahorse Bioscience Ranks No. 1600 on the Inc. 500|5000 List of Fastest-Growing Private Companies in America for 2012 with Three-Year Sales Growth of 183%

August 22, 2012